[HTML][HTML] Depletion of CD4+ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques

AM Ortiz, NR Klatt, B Li, Y Yi, B Tabb… - The Journal of …, 2011 - Am Soc Clin Investig
AM Ortiz, NR Klatt, B Li, Y Yi, B Tabb, XP Hao, L Sternberg, B Lawson, PM Carnathan…
The Journal of clinical investigation, 2011Am Soc Clin Investig
CD4+ T cells play a central role in the immunopathogenesis of HIV/AIDS, and their depletion
during chronic HIV infection is a hallmark of disease progression. However, the relative
contribution of CD4+ T cells as mediators of antiviral immune responses and targets for virus
replication is still unclear. Here, we have generated data in SIV-infected rhesus macaques
(RMs) that suggest that CD4+ T cells are essential in establishing control of virus replication
during acute infection. To directly assess the role of CD4+ T cells during primary SIV …
CD4+ T cells play a central role in the immunopathogenesis of HIV/AIDS, and their depletion during chronic HIV infection is a hallmark of disease progression. However, the relative contribution of CD4+ T cells as mediators of antiviral immune responses and targets for virus replication is still unclear. Here, we have generated data in SIV-infected rhesus macaques (RMs) that suggest that CD4+ T cells are essential in establishing control of virus replication during acute infection. To directly assess the role of CD4+ T cells during primary SIV infection, we in vivo depleted these cells from RMs prior to infecting the primates with a pathogenic strain of SIV. Compared with undepleted animals, CD4+ lymphocyte–depleted RMs showed a similar peak of viremia, but did not manifest any post-peak decline of virus replication despite CD8+ T cell– and B cell–mediated SIV-specific immune responses comparable to those observed in control animals. Interestingly, depleted animals displayed rapid disease progression, which was associated with increased virus replication in non-T cells as well as the emergence of CD4-independent SIV-envelopes. Our results suggest that the antiviral CD4+ T cell response may play an important role in limiting SIV replication, which has implications for the design of HIV vaccines.
The Journal of Clinical Investigation